154 related articles for article (PubMed ID: 11367862)
1. [Effect of ciprofibrate on the endothelial dysfunction of patients with combined dyslipidemia].
Kovács I; Tarján J; Császár A
Orv Hetil; 2001 Apr; 142(15):775-9. PubMed ID: 11367862
[TBL] [Abstract][Full Text] [Related]
2. The effect of ciprofibrate on flow-mediated dilation and inflammatory markers in patients with combined hyperlipidemia.
Kovács I; Toldy E; Abel T; Tarján J; Császár A
Endothelium; 2005; 12(4):179-83. PubMed ID: 16162440
[TBL] [Abstract][Full Text] [Related]
3. Ciprofibrate treatment decreases non-high density lipoprotein cholesterol and triglycerides and increases high density lipoprotein cholesterol in patients with Frederickson type IV dyslipidemia phenotype.
Bermúdez-Pirela V; Souki A; Cano-Ponce C; Bermúdez-Arias F; Mengual-Moreno E; Leal-Gonzalez E; Lemus-Antepaz M; de Bravo MC; de Díaz AA; de Pirela NL; Cano-Peñaloza R; Puche-Medina G; Arraiz N; Reyna-Villazmil N; Contreras F; Israili ZH; Valasco M
Am J Ther; 2007; 14(2):213-20. PubMed ID: 17414592
[TBL] [Abstract][Full Text] [Related]
4. Artichoke juice improves endothelial function in hyperlipemia.
Lupattelli G; Marchesi S; Lombardini R; Roscini AR; Trinca F; Gemelli F; Vaudo G; Mannarino E
Life Sci; 2004 Dec; 76(7):775-82. PubMed ID: 15581909
[TBL] [Abstract][Full Text] [Related]
5. [The new atherogenic plasma index reflects the triglyceride and HDL-cholesterol ratio, the lipoprotein particle size and the cholesterol esterification rate: changes during lipanor therapy].
Dobiásová M; Frohlich J
Vnitr Lek; 2000 Mar; 46(3):152-6. PubMed ID: 11048517
[TBL] [Abstract][Full Text] [Related]
6. Comparison of combined statin-fibrate treatment to monotherapy in patients with mixed hyperlipidemia.
Kłosiewicz-Latoszek L; Szostak WB; Grzybowska B; Białobrzeska-Paluszkiewicz J; Wiśniewska B; Stolarska I
Kardiol Pol; 2004 Jun; 60(6):567-77. PubMed ID: 15334157
[TBL] [Abstract][Full Text] [Related]
7. Etofibrate therapy and effect of added low-dose cholestyramine in patients with combined hyperlipidaemia.
Krüger B
Int J Clin Pharmacol Res; 1994; 14(5-6):177-83. PubMed ID: 7672874
[TBL] [Abstract][Full Text] [Related]
8. Early detection of atherosclerosis in type 2 diabetic patients by endothelial dysfunction and intima-media thickness.
Ifrim S; Vasilescu R
Rom J Intern Med; 2004; 42(2):343-54. PubMed ID: 15529625
[TBL] [Abstract][Full Text] [Related]
9. Prothrombotic and lipoprotein variables in patients attending a cardiovascular risk management clinic: response to ciprofibrate or lifestyle advice.
Mikhailidis DP; Ganotakis ES; Spyropoulos KA; Jagroop IA; Byrne DJ; Winder AF
Int Angiol; 1998 Dec; 17(4):225-33. PubMed ID: 10204653
[TBL] [Abstract][Full Text] [Related]
10. Factors associated with changes in serum total cholesterol levels over 7 years in middle-aged New Zealand men and women: a prospective study.
Metcalf PA; Scragg RK; Swinburn BA; Shaw LM
Nutr Metab Cardiovasc Dis; 2001 Oct; 11(5):298-305. PubMed ID: 11887426
[TBL] [Abstract][Full Text] [Related]
11. [Effect of long-term cardiac training on lipids concentration in patients with chronic heart ischemic disease treated with simvastatin].
Kałka D; Sobieszczańska M; Kopka L; Marciniak W; Zawadzka-Bartczak E; Bak A; Popielewicz-Kautz A; Korzeniowska J; Janczak J; Adamus J
Pol Merkur Lekarski; 2007 Feb; 22(128):101-6. PubMed ID: 17598652
[TBL] [Abstract][Full Text] [Related]
12. The influence of low-dose atorvastatin on lipid levels and endothelial vascular function in patients with significant coronary artery stenosis.
Kuryata OV; Yegorova YV
Kardiol Pol; 2006 Jan; 64(1):44-8; discussion 49-50. PubMed ID: 16444629
[TBL] [Abstract][Full Text] [Related]
13. Effect of ciprofibrate on lipoproteins, fibrinogen, renal function, and hepatic enzymes.
Rizos E; Bairaktari E; Ganotakis E; Tsimihodimos V; Mikhailidis DP; Elisaf M
J Cardiovasc Pharmacol Ther; 2002 Oct; 7(4):219-26. PubMed ID: 12490967
[TBL] [Abstract][Full Text] [Related]
14. Etofibrate decreases factor VII and fibrinogen levels in patients with polymetabolic syndrome.
Jastrzebska M; Torbus-Lisiecka B; Pieczul-Mróz J; Chelstowski K; Kopciewicz J; Naruszewicz M
Int J Clin Pharmacol Res; 1999; 19(1):19-25. PubMed ID: 10450539
[TBL] [Abstract][Full Text] [Related]
15. [The effect of shanzha xiaozhi capsule on the blood lipid and the function of endothelial cells in patients with dislipide mia].
Zhao HY; Wang WH
Zhong Yao Cai; 2006 Jun; 29(6):629-31. PubMed ID: 17039887
[TBL] [Abstract][Full Text] [Related]
16. [Effectiveness of ciprofibrate. Open study in a Portuguese population].
Silva JM; Branco MC; Pereira M; Figueiredo H; Jesus LC; de Moura JP; Ferreira MR; Serra e Silva P
Rev Port Cardiol; 1995 Apr; 14(4):313-22, 284. PubMed ID: 7612280
[TBL] [Abstract][Full Text] [Related]
17. [Changes in serum lipids, plasma fibrinogen and other haemostatic parameters induced by ciprofibrate action in hyperlipidemic patients with and without coronary artery disease].
Espinosa RA; Rodríguez-Roa E; Nagy E; Mijares ME; Rodríguez-Larralde A; Gil A; Lundberg U; Carvajal Z; Castillo L; Arocha-Piñango CL
Invest Clin; 2006 Mar; 47(1):35-48. PubMed ID: 16562643
[TBL] [Abstract][Full Text] [Related]
18. Does obesity influence ciprofibrate activity?
Silva JM; Serra e Silva P
Rev Port Cardiol; 1998 Apr; 17(4):329-34. PubMed ID: 9632956
[TBL] [Abstract][Full Text] [Related]
19. Early effects on endothelial function of atorvastatin 40 mg twice daily and its withdrawal.
Taneva E; Borucki K; Wiens L; Makarova R; Schmidt-Lucke C; Luley C; Westphal S
Am J Cardiol; 2006 Apr; 97(7):1002-6. PubMed ID: 16563905
[TBL] [Abstract][Full Text] [Related]
20. Serum lipid profiles including non-high density lipoprotein cholesterol levels in Turkish school-children.
Uçar B; Kiliç Z; Dinleyici EC; Colak O; Güneş E
Anadolu Kardiyol Derg; 2007 Dec; 7(4):415-20. PubMed ID: 18065339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
